Evaluation of new cardiovascular therapies - Conceptual and regulatory hurdles

被引：0

|

作者：

Ellis, SG

机构：

来源：

JOURNAL OF INVASIVE CARDIOLOGY | 1997年 / 9卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：126 / 130

页数：5

相关论文

共 50 条

[1] Hurdles in developing new Advanced Therapies: the experience with Holoclar
Chiesi, A.
HUMAN GENE THERAPY, 2016, 27 (11) : A4 - A4
[2] USE OF NEW THERAPIES PRIOR TO AUTHORIZATION: REIMBURSEMENT HURDLES IN GERMANY
Mueller, E.
Neeser, K.
Oelze, I. B.
VALUE IN HEALTH, 2020, 23 : S337 - S338
[3] Jumping the regulatory hurdles
Abrams, Fern
Printed Circuit Fabrication, 2000, 23 (10):
[4] European regulatory hurdles and prospects for new biocontrol product development
Kiewnick, S.
PHYTOPATHOLOGY, 2006, 96 (06) : S156 - S156
[5] Hurdles to the introduction of new therapies for immune-mediated kidney diseases
Hans-Joachim Anders
David R. W. Jayne
Brad H. Rovin
Nature Reviews Nephrology, 2016, 12 : 205 - 216
[6] Hurdles to the introduction of new therapies for immune-mediated kidney diseases
Anders, Hans-Joachim
Jayne, David R. W.
Rovin, Brad H.
NATURE REVIEWS NEPHROLOGY, 2016, 12 (04) : 205 - 216
[7] More regulatory hurdles to jump
Pinto, Jude
2003, Horizon House (37):
[8] Regulatory hurdles for agriculture GMOs
Hackett, Perry
Carroll, Dana
SCIENCE, 2015, 347 (6228) : 1324 - 1324
[9] Emerging Therapies Face Development Hurdles
Mirasol, Feliza
BIOPHARM INTERNATIONAL, 2022, 35 (05) : 10 - +
[10] Regulatory hurdles have not killed growth
Morrison, S
Schmitt, B
CHEMICAL WEEK, 2001, 163 (33) : 24 - 24

← 1 2 3 4 5 →